Masitinib Clinical Trials (2026): 36 Studies for Mastocytosis & Coronavirus Disease 2019

Where to Participate: All Masitinib Trial Sites in the U.S. (6 sites across 6 states)

Every actively recruiting Masitinibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Masitinib clinical trials at a glance: phase × recruitment status

Recruiting Masitinib clinical trials (3)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Masitinib clinical trials by indication

Masitinib pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn Masitinib trials (7)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT05441488suspendedMasitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
• NCT01280565terminatedMasitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit
• NCT00812240terminatedMasitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
• NCT02605044terminatedMasitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
• NCT01470131terminatedA Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
• NCT02009423terminatedMasitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence
• NCT01410695terminatedMasitinib in Refractory Active Rheumatoid Arthritis

All Masitinib trials (36)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Masitinib clinical trials: frequently asked questions

How many Masitinib clinical trials are there?

36 Masitinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 22 are marked completed.

Are Masitinib clinical trials recruiting in 2026?

Yes — 1 Masitinib trial is actively recruiting in 2026, with 6 U.S. sites across 6 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Masitinib being studied for?

Masitinib is being studied for Mastocytosis, Coronavirus Disease 2019, Amyotrophic Lateral Sclerosis (ALS), Gastrointestinal Stromal Tumors, Multiple Myeloma and 28 more. The trials are grouped by indication on this page.

What phase is Masitinib in?

Masitinib clinical trials span 19 Phase 3, 13 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Masitinib clinical trials?

The lead sponsor across the most Masitinib trials is AB Science. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Masitinibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.